P

Inventor

DUCLOS OLIVIER

FR21 patents
⚠️ This page may combine multiple inventors who share the name “DUCLOS OLIVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SANOFI SA

12 patents
US10220044B2Mar 5, 2019

Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

SANOFI SA3 citations82
US9744176B2Aug 29, 2017

Therapeutic uses of novel thienopyrimidine derivatives

SANOFI SA4 citations82
US9115140B2Aug 25, 2015

Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

SANOFI SA5 citations82
US10500212B2Dec 10, 2019

Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

SANOFI SA2 citations71
US10988524B2Apr 27, 2021

Modified relaxin B chain peptides and their therapeutic use

SANOFI SA2 citations70
US10961295B2Mar 30, 2021

Modified lipidated Relaxin B chain peptides and their therapeutic use

SANOFI SA2 citations69
US10988523B2Apr 27, 2021

Modified lipidated Relaxin B chain peptides and their therapeutic use

SANOFI SA2 citations68
US10980816B2Apr 20, 2021

Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

SANOFI SA0 citations61
US11725036B2Aug 15, 2023

Modified lipidated relaxin B chain peptides and their therapeutic use

SANOFI SA0 citations59
US8686150B2Apr 1, 2014

6-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

SANOFI SA3 citations57
US10736904B2Aug 11, 2020

Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

SANOFI SA0 citations50
US9675606B2Jun 13, 2017

2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors

SANOFI SA0 citations47

PLETTENBURG OLIVER

3 patents

ALAM ANTOINE

2 patents

BENAZET ALEXANDRE

1 patent

BRAUN ALAIN

1 patent

LOEHN MATTHIAS

1 patent

BEAUVERGER PHILIPPE

1 patent